Short answer · Medically reviewed summary · Last updated: 2026-05-08
Congenital Adrenal Hyperplasia (CAH) is a hereditary genetic condition caused by mutations in genes involved in cortisol production, most commonly the CYP21A2 gene. Because it follows an autosomal recessive inheritance pattern, a child must inherit one mutated gene from each parent to be affected by Congenital Adrenal Hyperplasia (CAH). Is Congenital Adrenal Hyperplasia (CAH) hereditary? Yes, Congenital Adrenal Hyperplasia (CAH) is strictly hereditary.
1 people with Congenital Adrenal Hyperplasia (CAH) have shared their first-person experience on this question at DiseaseMaps.
Is Congenital Adrenal Hyperplasia (CAH) hereditary?
Is Congenital Adrenal Hyperplasia (CAH) hereditary? The genetic component explained in plain language, reviewed against medical sources, with patient experiences.
Congenital Adrenal Hyperplasia (CAH) is a hereditary genetic condition caused by mutations in genes involved in cortisol production, most commonly the CYP21A2 gene. Because it follows an autosomal recessive inheritance pattern, a child must inherit one mutated gene from each parent to be affected by Congenital Adrenal Hyperplasia (CAH).
Is Congenital Adrenal Hyperplasia (CAH) hereditary?
Yes, Congenital Adrenal Hyperplasia (CAH) is strictly hereditary. It is not caused by lifestyle or environmental factors. In an autosomal recessive inheritance pattern, parents who are both asymptomatic carriers of a CYP21A2 mutation have a 25% chance with each pregnancy of having a child affected by Congenital Adrenal Hyperplasia (CAH). De novo (spontaneous) mutations are extremely rare in this condition, meaning the vast majority of cases are inherited from parents who carry the gene variant.
What is the role of genetic testing and counseling?
Genetic testing is the gold standard for confirming a diagnosis of Congenital Adrenal Hyperplasia (CAH) and identifying carrier status in family members. Genetic counseling is highly recommended for families planning a pregnancy or those who have a family history of the condition. Counselors help families understand the following:
- Carrier testing: Identifying if prospective parents carry a recessive mutation.
- Prenatal diagnosis: Options such as chorionic villus sampling or amniocentesis for high-risk pregnancies.
- Recurrence risk: The 25% statistical probability for siblings of an affected individual.
- Family planning: Discussion of reproductive technologies like PGT-M (preimplantation genetic testing for monogenic disorders).
Next steps
- Consult with a clinical geneticist to discuss specific CYP21A2 mutation testing.
- Connect with the 81 members of the Congenital Adrenal Hyperplasia (CAH) community on DiseaseMaps.org for peer support.
- Speak with an endocrinologist to manage hormone replacement therapy effectively.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases (GARD) Information Center: Congenital Adrenal Hyperplasia
- Orphanet: Congenital Adrenal Hyperplasia (ORPHA:182)
- OMIM (Online Mendelian Inheritance in Man): 21-Hydroxylase Deficiency (#201910)
- CARES Foundation (Congenital Adrenal Hyperplasia Research, Education & Support)
Posted Jun 12, 2018 by Dena 3550
